The calcium channel blocker controversy - a caution to physicians and pharmacist.
Eliot
L
L
Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.
D000787:Angina Pectoris / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004304:Dosage Forms; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D015201:Meta-Analysis as Topic; D009203:Myocardial Infarction / Q000188:drug therapy
D002121:Calcium Channel Blockers; D004304:Dosage Forms